SAPIEN has become most commonly used valve to treat native RVOT regurgitation since 2020 after Melody dominated the early years
Transcatheter pulmonary valve replacement (TPVR) has increased since it was approved in the U.S. in 2010 to treat regurgitant native right ventricular outflow tract (RVOT) anatomy, and the SAPIEN valve is the most commonly used device in recent years, according to a new analysis of real-world data.